# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 15, "Pharmacotherapy", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasJournal> \"Pharmacotherapy\"."
1, PublicationYear, 18, 22, "2015", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasPublicationYear> \"2015\"."
21, Title, 102, 273, "Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy : A Placebo - Controlled Trial .", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasTitle> \"Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy : A Placebo - Controlled Trial .\"."
100165, Acarbose, 112, 120, "Acarbose", "", 
14, Precondition, 148, 240, "Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy", "", "<http://ctro/data#Population_68540> <http://ctro/data#hasPrecondition> \"Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy\"."
10, Type2Diabetes, 180, 204, "Type 2 Diabetes Mellitus", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
15, Placebo, 245, 252, "Placebo", "", 
22, Author, 274, 282, "Derosa G", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasAuthor> \"Derosa G\"."
23, Author, 303, 314, "Franzetti I", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasAuthor> \"Franzetti I\"."
24, Author, 323, 331, "Querci F", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasAuthor> \"Querci F\"."
25, Author, 340, 352, "D ' Angelo A", "", 
26, Author, 367, 377, "Maffioli P", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasAuthor> \"Maffioli P\"."
27, Italy, 546, 551, "Italy", "", 
28, Italy, 676, 681, "Italy", "", 
29, Italy, 755, 760, "Italy", "", 
30, Italy, 836, 841, "Italy", "", 
31, Italy, 906, 911, "Italy", "", 
32, Italy, 988, 993, "Italy", "", 
40, ObjectiveDescription, 1014, 1255, "To evaluate the effect of acarbose on glycemic control and glycemic variability , using a continuous glucose - monitoring system , in patients with type 2 diabetes mellitus who were not well controlled on metformin and vildagliptin therapy .", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasObjectiveDescription> \"To evaluate the effect of acarbose on glycemic control and glycemic variability , using a continuous glucose - monitoring system , in patients with type 2 diabetes mellitus who were not well controlled on metformin and vildagliptin therapy .\"."
100163, Acarbose, 1040, 1048, "acarbose", "", 
39, Precondition, 1148, 1253, "patients with type 2 diabetes mellitus who were not well controlled on metformin and vildagliptin therapy", "", "<http://ctro/data#Population_68540> <http://ctro/data#hasPrecondition> \"patients with type 2 diabetes mellitus who were not well controlled on metformin and vildagliptin therapy\"."
11, Type2Diabetes, 1162, 1186, "type 2 diabetes mellitus", "", 
33, Metformin, 1219, 1228, "metformin", "", 
36, Vildagliptin, 1233, 1245, "vildagliptin", "", 
41, Multicenter, 1265, 1276, "Multicenter", "", 
42, Randomized, 1279, 1289, "randomized", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
43, DoubleBlind, 1292, 1306, "double - blind", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
16, Placebo, 1309, 1316, "placebo", "", 
145, Multicenter, 1375, 1390, "three hospitals", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
146, Italy, 1394, 1399, "Italy", "", "<http://ctro/data#Population_68540> <http://ctro/data#hasCountry> <http://ctro/data#Italy>."
147, NumberPatientsCT, 1413, 1426, "Fifty - three", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasNumberPatientsCT> \"Fifty - three\"."
12, Type2Diabetes, 1441, 1456, "type 2 diabetes", "", 
46, Metformin, 1491, 1500, "metformin", "", 
48, DoseValue, 1501, 1504, "850", "", 
50, mg, 1505, 1507, "mg", "", 
52, Frequency, 1508, 1521, "3 times / day", "", 
47, Vildagliptin, 1526, 1538, "vildagliptin", "", 
49, DoseValue, 1539, 1541, "50", "", 
51, mg, 1542, 1544, "mg", "", 
53, Frequency, 1545, 1556, "twice / day", "", 
54, Duration, 1570, 1578, "3 months", "", 
56, Randomized, 1670, 1680, "randomized", "", 
17, Placebo, 1691, 1698, "placebo", "", "<http://ctro/data#Medication_68597> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
100164, Acarbose, 1702, 1710, "acarbose", "", 
57, DoseValue, 1711, 1714, "100", "", "<http://ctro/data#Medication_68590> <http://ctro/data#hasDoseValue> \"100\"."
58, mg, 1715, 1717, "mg", "", "<http://ctro/data#Medication_68590> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
59, Frequency, 1718, 1731, "3 times / day", "", "<http://ctro/data#Intervention_68566> <http://ctro/data#hasFrequency> \"3 times / day\"."
34, Metformin, 1753, 1762, "metformin", "", 
37, Vildagliptin, 1765, 1777, "vildagliptin", "", 
60, MeasurementDevice, 1865, 1903, "continuous glucose - monitoring system", "", 
167, Duration, 1908, 1914, "1 week", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasCTduration> \"1 week\"."
100175, Mean, 1955, 1959, "mean", "", "<http://ctro/data#Mean_68629> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_68627> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_68629>."
100173, BloodGlucose, 1960, 1973, "blood glucose", "", "<http://ctro/data#Endpoint_68627> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BloodGlucose>."
62, BloodGlucose, 1976, 1979, "MBG", "", 
100176, EndPointDescription, 1994, 2080, "area under the glucose concentration - time curve for a glucose level above 70 mg / dl", "", "<http://ctro/data#EndPointDescription_68696> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_68695> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_68696>."
63, Mg_per_deciliter, 2073, 2080, "mg / dl", "", 
186, EndPointDescription, 2083, 2095, "AUC above 70", "", 
187, EndPointDescription, 2101, 2112, "180 mg / dl", "", 
64, Mg_per_deciliter, 2105, 2112, "mg / dl", "", 
188, EndPointDescription, 2115, 2128, "AUC above 180", "", "<http://ctro/data#EndPointDescription_68760> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_68759> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_68760>."
195, EndPointDescription, 2137, 2203, "the percentage of time that the glucose level was above 70 mg / dl", "", 
65, Mg_per_deciliter, 2196, 2203, "mg / dl", "", 
196, EndPointDescription, 2206, 2216, "T above 70", "", 
197, EndPointDescription, 2222, 2233, "180 mg / dl", "", 
66, Mg_per_deciliter, 2226, 2233, "mg / dl", "", 
198, EndPointDescription, 2236, 2247, "T above 180", "", "<http://ctro/data#EndPointDescription_68828> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_68827> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_68828>."
67, BloodGlucose, 2328, 2341, "blood glucose", "", 
78, EndPointDescription, 2354, 2391, "mean amplitude of glycemic excursions", "", "<http://ctro/data#EndPointDescription_68896> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_68895> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_68896>."
77, EndPointDescription, 2394, 2398, "MAGE", "", 
79, EndPointDescription, 2407, 2414, "M value", "", 
83, EndPointDescription, 2522, 2546, "mean of daily difference", "", "<http://ctro/data#EndPointDescription_68928> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_68927> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_68928>."
82, EndPointDescription, 2549, 2553, "MODD", "", 
68, EndPointDescription, 2562, 2565, "MBG", "", 
85, ObservedResult, 2572, 2703, "was ~ 20 mg / dl lower in the acarbose group than in the placebo group ( p < 0 . 05 ) , particularly during the postprandial period", "", "<http://ctro/data#Outcome_68632> <http://ctro/data#hasObservedResult> \"was ~ 20 mg / dl lower in the acarbose group than in the placebo group ( p < 0 . 05 ) , particularly during the postprandial period\". <http://ctro/data#Outcome_68659> <http://ctro/data#hasObservedResult> \"was ~ 20 mg / dl lower in the acarbose group than in the placebo group ( p < 0 . 05 ) , particularly during the postprandial period\"."
180, DiffGroupAbsValue, 2576, 2580, "~ 20", "", "<http://ctro/data#DiffBetweenGroups_68686> <http://ctro/data#hasDiffGroupAbsValue> \"~ 20\"."
84, Mg_per_deciliter, 2581, 2588, "mg / dl", "", "<http://ctro/data#Endpoint_68627> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Mg_per_deciliter>."
100166, Acarbose, 2602, 2610, "acarbose", "", 
18, Placebo, 2629, 2636, "placebo", "", 
183, PvalueDiff, 2645, 2655, "p < 0 . 05", "", "<http://ctro/data#DiffBetweenGroups_68686> <http://ctro/data#hasPvalueDiff> \"p < 0 . 05\"."
184, EndPointDescription, 2710, 2722, "AUC above 70", "", 
97, ObservedResult, 2723, 2774, "did not significantly differ between the two groups", "", "<http://ctro/data#Outcome_68700> <http://ctro/data#hasObservedResult> \"did not significantly differ between the two groups\". <http://ctro/data#Outcome_68727> <http://ctro/data#hasObservedResult> \"did not significantly differ between the two groups\"."
189, EndPointDescription, 2789, 2802, "AUC above 180", "", 
98, ObservedResult, 2803, 2886, "was ~ 40 % lower in the acarbose group than in the placebo group during the daytime", "", "<http://ctro/data#Outcome_68764> <http://ctro/data#hasObservedResult> \"was ~ 40 % lower in the acarbose group than in the placebo group during the daytime\". <http://ctro/data#Outcome_68791> <http://ctro/data#hasObservedResult> \"was ~ 40 % lower in the acarbose group than in the placebo group during the daytime\"."
190, DiffGroupRelValue, 2807, 2811, "~ 40", "", "<http://ctro/data#DiffBetweenGroups_68818> <http://ctro/data#hasDiffGroupRelValue> \"~ 40\"."
100168, Acarbose, 2827, 2835, "acarbose", "", 
19, Placebo, 2854, 2861, "placebo", "", 
100, RelativeTime, 2879, 2886, "daytime", "", 
101, PvalueDiff, 2889, 2899, "p < 0 . 01", "", "<http://ctro/data#DiffBetweenGroups_68818> <http://ctro/data#hasPvalueDiff> \"p < 0 . 01\"."
199, EndPointDescription, 2908, 2919, "T above 180", "", 
20, Placebo, 2952, 2959, "placebo", "", 
100169, Acarbose, 2978, 2986, "acarbose", "", 
102, ResultMeasuredValue, 2995, 2997, "31", "", "<http://ctro/data#Outcome_68859> <http://ctro/data#hasResultMeasuredValue> \"31\"."
104, Percentage, 2998, 2999, "%", "", 
103, ResultMeasuredValue, 3003, 3004, "8", "", "<http://ctro/data#Outcome_68832> <http://ctro/data#hasResultMeasuredValue> \"8\"."
105, Percentage, 3005, 3006, "%", "", 
106, PvalueDiff, 3009, 3019, "p < 0 . 01", "", "<http://ctro/data#DiffBetweenGroups_68886> <http://ctro/data#hasPvalueDiff> \"p < 0 . 01\"."
87, ObservedResult, 3033, 3118, "the standard deviation and MAGE values were significantly lower in the acarbose group", "", "<http://ctro/data#Outcome_68900> <http://ctro/data#hasObservedResult> \"the standard deviation and MAGE values were significantly lower in the acarbose group\"."
76, EndPointDescription, 3060, 3064, "MAGE", "", 
86, ObservedResult, 3121, 3245, "The MODD value was not significantly changed in either group , and no significant differences were recorded between groups .", "", "<http://ctro/data#Outcome_68932> <http://ctro/data#hasObservedResult> \"The MODD value was not significantly changed in either group , and no significant differences were recorded between groups .\". <http://ctro/data#Outcome_68959> <http://ctro/data#hasObservedResult> \"The MODD value was not significantly changed in either group , and no significant differences were recorded between groups .\"."
80, EndPointDescription, 3125, 3129, "MODD", "", 
93667, ObservedResult, 3246, 3289, "All adverse events were mild in both groups", "", "<http://ctro/data#Outcome_68991> <http://ctro/data#hasObservedResult> \"All adverse events were mild in both groups\". <http://ctro/data#Outcome_69018> <http://ctro/data#hasObservedResult> \"All adverse events were mild in both groups\"."
81, EndPointDescription, 3250, 3264, "adverse events", "", "<http://ctro/data#EndPointDescription_68987> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_68986> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_68987>."
207, EndPointDescription, 3339, 3349, "flatulence", "", "<http://ctro/data#EndPointDescription_69046> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_69045> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_69046>."
100170, Acarbose, 3363, 3371, "acarbose", "", 
213, PercentageAffected, 3380, 3381, "5", "", "<http://ctro/data#Outcome_69050> <http://ctro/data#hasPercentageAffected> \"5\"."
100171, Acarbose, 3389, 3397, "acarbose", "", 
214, PercentageAffected, 3401, 3406, "0 . 5", "", "<http://ctro/data#Outcome_69077> <http://ctro/data#hasPercentageAffected> \"0 . 5\"."
112, Placebo, 3414, 3421, "placebo", "", 
113, PvalueDiff, 3424, 3434, "p < 0 . 05", "", "<http://ctro/data#DiffBetweenGroups_69104> <http://ctro/data#hasPvalueDiff> \"p < 0 . 05\"."
114, ConclusionComment, 3452, 3662, "The addition of acarbose to metformin and vildagliptin background therapy in patients with inadequately controlled type 2 diabetes decreased intraday glycemic variability , especially postprandial variability ,", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasConclusionComment> \"The addition of acarbose to metformin and vildagliptin background therapy in patients with inadequately controlled type 2 diabetes decreased intraday glycemic variability , especially postprandial variability ,\"."
100172, Acarbose, 3468, 3476, "acarbose", "", 
35, Metformin, 3480, 3489, "metformin", "", 
38, Vildagliptin, 3494, 3506, "vildagliptin", "", 
13, Type2Diabetes, 3567, 3582, "type 2 diabetes", "", 
115, ConclusionComment, 3663, 3749, "but it was not associated with a significant change in interday glycemic variability .", "", "<http://ctro/data#ClinicalTrial_68524> <http://ctro/data#hasConclusionComment> \"but it was not associated with a significant change in interday glycemic variability .\"."
116, PMID, 3831, 3839, "26598090", "", "<http://ctro/data#Publication_68517> <http://ctro/data#hasPMID> \"26598090\"."
